AEON Biopharma, Inc.
AEON
$0.88
$0.00-0.23%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.01M | 5.93M | 8.44M | 10.45M | 13.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 392.00K | 1.49M | 1.82M | 1.88M | 1.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.40M | 7.41M | 10.26M | 12.32M | 1.59M |
|
|
|||||
| Total Current Assets | 3.40M | 7.41M | 10.26M | 12.32M | 1.59M |
| Net Property, Plant & Equipment | 1.21M | 1.29M | 1.37M | 1.45M | 1.52M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 948.00K | 29.00K | 29.00K | 29.00K | 29.00K |
| Total Assets | 5.56M | 8.73M | 11.66M | 13.80M | 3.14M |
|
|
|||||
| Total Accounts Payable | 942.00K | 2.53M | 3.91M | 2.44M | 5.91M |
| Total Accrued Expenses | 5.70M | 5.46M | 4.98M | 6.01M | 8.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 252.00K | 247.00K | 242.00K | 197.00K | 121.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.90M | 8.23M | 9.13M | 8.64M | 14.15M |
|
|
|||||
| Total Current Liabilities | 6.90M | 8.23M | 9.13M | 8.64M | 14.15M |
| Long-Term Debt | 34.60M | 17.05M | 15.17M | 13.32M | 11.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 893.00K | 957.00K | 1.02M | 1.08M | 1.15M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.20M | 2.37M | 2.19M | 2.08M | 4.73M |
| Total Liabilities | 60.59M | 28.61M | 27.51M | 25.12M | 31.71M |
|
|
|||||
| Common Stock & APIC | 415.79M | 413.81M | 413.29M | 411.18M | 403.03M |
| Retained Earnings | -470.82M | -433.68M | -429.14M | -422.50M | -431.60M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -55.03M | -19.87M | -15.85M | -11.32M | -28.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.03M | -19.87M | -15.85M | -11.32M | -28.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.03M | -19.87M | -15.85M | -11.32M | -28.57M |
|
|
|||||